{"DataElement":{"publicId":"3362002","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Serum HCG Measurement Diagnosis Score","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"Dise_FIGO_Seru_Diag_FIGO_Seru_","context":"NRG","contextVersion":"1","DataElementConcept":{"publicId":"3361992","version":"1","preferredName":"Disease or Disorder FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Serum HCG Measurement Diagnosis","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum._The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"Dise_FIGO_Seru_Diag","context":"NRG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3361990","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Serum HCG Measurement Diagnosis","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.:A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C99408:C73495:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Serum HCG Measurement","conceptCode":"C73495","definition":"A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D395-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D3A6-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3361997","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Serum HCG Measurement Score","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk._A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum._A number or range of numeric values measuring performance, function, quality, or ability.","longName":"FIGO_Seru_Scor","context":"NRG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"GREATER THAN OR EQUAL TO 10^5","valueDescription":"SCORE 4-SERUM BETA-hCG GREATER THAN OR EQUAL TO 10^5","ValueMeaning":{"publicId":"3361998","version":"1","preferredName":"SCORE 4-SERUM BETA-hCG GREATER THAN OR EQUAL TO 10^5","longName":"3361998","preferredDefinition":"SCORE 4-SERUM BETA-hCG GREATER THAN OR EQUAL TO 10^5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-10D1-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749402C-10EA-FCFF-E040-BB89AD433131","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"},{"value":"10^4 TO LESS THAN 10^5","valueDescription":"SCORE 2-SERUM BETA-hCG 10^4 TO LESS THAN 10^5","ValueMeaning":{"publicId":"3361999","version":"1","preferredName":"SCORE 2-SERUM BETA-hCG 10^4 TO LESS THAN 10^5","longName":"3361999","preferredDefinition":"SCORE 2-SERUM BETA-hCG 10^4 TO LESS THAN 10^5","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-10F4-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749402C-110D-FCFF-E040-BB89AD433131","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"},{"value":"10^3 TO LESS THAN 10^4","valueDescription":"SCORE 1-SERUM BETA-hCG 10^3 TO LESS THAN 10^4","ValueMeaning":{"publicId":"3362000","version":"1","preferredName":"SCORE 1-SERUM BETA-hCG 10^3 TO LESS THAN 10^4","longName":"3362000","preferredDefinition":"SCORE 1-SERUM BETA-hCG 10^3 TO LESS THAN 10^4","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-1117-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749402C-1130-FCFF-E040-BB89AD433131","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"},{"value":"LESS THAN 10^3","valueDescription":"SCORE 0-SERUM BETA-hCG IS LESS THAN 10^3","ValueMeaning":{"publicId":"3362001","version":"1","preferredName":"SCORE 0-SERUM BETA-hCG IS LESS THAN 10^3","longName":"3362001","preferredDefinition":"SCORE 0-SERUM BETA-hCG IS LESS THAN 10^3","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-113A-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B749402C-1153-FCFF-E040-BB89AD433131","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3361996","version":"1","preferredName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms Serum HCG Measurement Score","preferredDefinition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.:A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum.:A number or range of numeric values measuring performance, function, quality, or ability.","longName":"C99408:C73495:C25338","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"FIGO Staging System and Modified World Health Organization [WHO] Prognostic Scoring System for Gestational Trophoblastic Neoplasms","conceptCode":"C99408","definition":"A system for defining prognosis for gestational trophoblastic neoplasia. In this system, the FIGO stage is represented by an Roman numeral, followed by the modified WHO score depicted as an Arabic numeral and separated by a colon (e.g., Stage II:4, Stage IV:9). Scores of 0-6 are considered low-risk and scores greater than 6 are considered high-risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Serum HCG Measurement","conceptCode":"C73495","definition":"A quantitative measurement of the amount of human chorionic gonadotropin present in a sample of serum.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Score","conceptCode":"C25338","definition":"A number or range of numeric values measuring performance, function, quality, or ability.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-10AE-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"ONEDATA","dateModified":"2012-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749402C-10BF-FCFF-E040-BB89AD433131","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"SBR","dateModified":"2013-08-01","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4104991","version":"1","longName":"GOG-0275","context":"NRG"}]}],"AlternateNames":[{"name":"Dise_FIGO_Seru_Diag_FIGO_Seru_","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Serum Beta-hCG WHO Score","type":"Preferred Question Text","description":"Serum Beta-hCG WHO Score","url":null,"context":"CTEP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B749E724-D3FF-0EC8-E040-BB89AD43503D","latestVersionIndicator":"Yes","beginDate":"2012-01-24","endDate":null,"createdBy":"REBOYJ","dateCreated":"2012-01-24","modifiedBy":"FORMBUILDER","dateModified":"2014-09-02","changeDescription":" Changed from CTEP to GOG for REBOYJ by script Thu Aug 1 14:45:44 EDT 2013","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}